SLC27A6 is used as a predictor in the genetic analysis of colorectal cancer, prostate cancer, pancreatic cancer, and other tumors (Mohammed et al., 2019; Uhan et al., 2020; Verma et al., 2020; Zhong et al., 2021). Here, SLC27A6 is linked to familial pancreatic carcinoma.